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Abstract 
Pannexin 3 (Panx3) is a channel forming glycoprotein that is highly expressed in skeletal 
tissues. Panx3 is induced at the growth plate of long bones where it regulates cell 
proliferation and differentiation, a key role in bone formation.  
This study analyzes the phenotype of long bones in a novel Panx3 knockout (KO) mouse to 
assess the role of Panx3 in bone formation.  
Ten KO and 10 wild-type (WT) adult mice were scanned using in vivo micro-CT. Right 
femora / humeri were digitized using homologous landmarks. Geometric morphometric 
analysis (multivariate statistical methods) allowed for quantitative comparison of shape, size 
and variation between KO and WT long bones.  
KO mice demonstrated distinct long bone shape differences. A significant amount of this 
difference, 20-30%, can be attributed to the allometric component of shape.  When scaled, 
WT bones have proportionally longer diaphyses and KO bones have larger bony 
prominences and epiphyses.  
Analysis of long bone cross-sectional geometric properties revealed thicker diaphyses in KO 
mice, equaling greater resistance to torsion and compression. 
KO mice appear to have altered long bone growth patterns, implicating a role for Panx3 in 
maintaining optimum skeletal growth. 
Keywords 
Pannexin, Panx3, geometric morphometrics, EDMA, principal components analysis, 
Diaphyseal cross-section, femur, humerus, long bone 
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1 Background 
 
Communication amongst cells is essential for normal function and development in an 
organism. To accomplish adequate communication, cells use channels that span the 
membranes of adjacent cells, known as gap junctions, and single-membrane channels 
connecting intracellular and extracellular regions.  In chordates, gap junctions and 
hemichannels (half of a cell to cell channel) are formed by a family of proteins knows as 
connexins. Invertebrate cells use an unrelated, but topologically similar family of proteins 
known as innexins to form gap junctions.  
 
In the search for innexin homologues in chordates, a new class of pore forming proteins 
now known as pannexins were identified in 2000 (Panchin et al. 2000).  Pannexins are a 
class of transmembrane glycoproteins found in chordates that have limited sequence 
homology with innexins (Panchin et al. 2000). Although pannexins were initially thought 
to function in a similar manner to innexins, forming gap junctions for intercellular 
communication, the majority of evidence now indicates that pannexin proteins function to 
form single-membrane channels connecting the intracellular and extracellular 
compartments (Penuela et al. 2007; Sosinsky et al. 2011; Penuela, Gehi, and Laird 2013). 
These channels facilitate the movement of ions and small molecules resulting in the 
induction of multiple signaling pathways; current evidence has identified pannexins as 
ATP release channels (Bao, Locovei, and Dahl 2004; Ishikawa et al. 2011) initiating 
signaling cascades (Scemes, Spray, and Meda 2008; Penuela et al. 2014; Ishikawa et al. 
2011).  
 
There are three members of the pannexin protein family, Panx1, Panx2 and Panx3. The 
role of each pannexin in cellular processes continues to be discovered, but most cell types 
express at least one of the pannexins (Bond and Naus 2014). 
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1.1 Pannexin Structure 
 
All members of the pannexin family have 4 transmembrane domains, 2 extracellular 
loops, 1 intracellular loop, and cytoplasmic terminal domains (Baranova et al. 2004) 
(Figure 1). The three pannexins vary in their amino acid lengths; Panx2 is the largest and 
all members contain two cysteine residues in each extracellular loop and undergo 
glycosylation at specific sites (Penuela, Gehi, and Laird 2013) (Figure 1). Panx1 and 
Panx3 each exist in three forms that are dependent upon their glycosylation. Different 
forms are localized to particular parts of the cell and glycosylation also appears important 
for Panx1 and Panx3 to properly reach the cell surface (Boassa et al. 2007; Penuela et al. 
2007). Panx1 is known to associate with several proteins; Panx1 was shown to interact 
with actin at its C-terminal tail as well as to form an association with several other 
proteins that appear to control gating and cell trafficking (Bond and Naus 2014).  
 
Biochimica et biophysica acta. Biomembranes by ELSEVIER BV. Reproduced with permission of 
ELSEVIER BV in the format Thesis/Dissertation (Penuela, Gehi, and Laird 2013) 
Figure 1. Diagram depicting the three pannexins. Each member differs in amino acid length 
with Panx2 being the largest. All members have 4 transmembrane domains, 2 extracellular 
loops (EL1, EL2), 1 intracellular loop (IL), and cytoplasmic terminal domains, CT 
(carboxy-terminus) and NT (amino-terminus). All have specific sites of glycosolation and 
two cysteine residues (C) in each extracelluar loop. Subunits oligomerize to form channels.  
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Pannexin subunits oligomerize to form channels called pannexons (Figure 1). Panx1 
oligomerizes into hexameric structures to form a channel, while Panx2 forms heptamers 
or octamers. Oligomerization data for Panx3 is still outstanding, although it is predicted 
to also form hexamers since it has a similar polypeptide sequence and size as Panx1 
(Penuela, Gehi, and Laird 2013).   
 
Members of the pannexin family have been reported to interact to form intermixed 
channels: Panx1 with Panx2 or Panx1 with Panx3 (Bruzzone et al. 2005; Bond and Naus 
2014; Penuela et al. 2009). There appears to be no change in function associated with 
mixing of Panx1 with Panx3, although the Panx1/2 configuration results in diminished 
function of the channel (Bruzzone et al. 2005; Penuela et al. 2009) and is unstable when 
isolated (Ambrosi et al. 2010). This intermixing of pannexins along with evidence of 
phenotypes that can be observed only in double knockout pannexin mice suggests that 
members of the pannexin family may compensate for each other when one is absent or 
insufficient. In this respect, it is also notable that Panx2 and Panx3 are often co-expressed 
in tissues with Panx1 (Penuela et al. 2009). 
 
1.2 Expression of Pannexins 
 
All three pannexins have been identified in various chordate species including humans, 
mice, rats, dogs, cows, zebrafish, and puffer fish (Yen and Saier Jr 2007). Notably, 
human pannexins have up to 94% conserved sequence homologies with murine 
pannexins (Penuela et al. 2009).  
 
Pannexins have been characterized in a number of human and murine tissues.  Panx1 is 
the most extensively studied of the pannexin family and has the most widespread tissue 
distribution; it has been identified in brain, heart, skeletal muscle, skin, testis, ovary, 
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placenta, thymus, prostate, lung, liver, small intestine, pancreas, spleen, colon, 
endothelium, and erythrocytes (Baranova et al. 2004). Panx1 has also been detected in 
chondrocytes and in osteoblasts (Penuela, Gehi, and Laird 2013; Bond and Naus 2014; 
Moon et al. 2015). Panx2 expression is limited mainly to areas of the brain (Bruzzone et 
al. 2003; Baranova et al. 2004).  
 
Of the three pannexins, Panx3 is the least studied and has the most limited expression 
profile. It is largely expressed in skeletal tissues and skin (Baranova et al. 2004; Penuela 
et al. 2007; Bond et al. 2011; Ishikawa et al. 2011), but has also been found in arterioles 
within the kidneys (Bond and Naus 2014) and in Leydig cells, the epididymis and 
efferent ducts of adult rats (Turmel et al. 2011). Recently, there is also evidence of Panx3 
in skeletal muscle tissues (Langlois et al. 2014).  
  
1.3 The Role of Pannexins in Physiology, 
Development and Disease 
 
In recent years, pannexins have been the subject of intense investigation as their roles in 
physiology and disease continue to be uncovered.  As outlined above, one or more of the 
pannexins are expressed in most mammalian tissues, indicating a potential link to many 
physiological and pathological processes. For example, Panx1 has been found to be 
involved in a diverse range of processes including vasodilation, vasoconstriction, taste 
sensation, viral infection, immune response, tumor suppression in gliomas vs tumor 
proliferation in melanomas, stroke, epilepsy, and regulation of keratinocytes in the skin   
(Penuela et al. 2014; Celetti et al. 2010; Cowan et al. 2012).  
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Panx2 has been found to have a role in neuronal differentiation and is reduced in gliomas 
(Lai, Bechberger, and Naus 2009). As well, Panx2 has been linked to ischaemia / stroke 
(Penuela et al. 2014). 
 
The only disease process linked to Panx3 thus far is osteoarthritis. Panx3 is upregulated 
in osteoarthritic cartilage, and knocking out the protein in cartilage has a protective effect 
against the development of osteoarthritis (Moon et al. 2015). In vitro studies have 
identified important roles for Panx3 in bone growth and development (Ishikawa et al. 
2014; Ishikawa et al. 2011; Iwamoto et al. 2010). These processes and the current 
understanding of Panx3’s role in formation and maintenance of the skeleton are discussed 
below.  
 
1.4  Exploring the Role of Panx3 in Bone Growth and 
Development 
 
In vitro studies to date have demonstrated that Panx3 is highly expressed in skeletal 
tissues. It is present in the developing growth plate of long bones, and is induced during 
the differentiation of chondrocytes (Iwamoto et al. 2010). Panx3 is also expressed in 
osteoblasts and promotes their differentiation (Ishikawa et al. 2011). Owing to the 
induction of Panx3 at the growth plate of developing long bones demonstrated in-vitro, it 
is expected that in-vivo, a lack of Panx3 will effect an observable phenotype related to 
long bones. To further explore the role of Panx3, a summary of long bone development 
by endochondral ossification is first provided, followed by a summary of our current 
knowledge of the role of Panx3 in the growth and development of long bones. Finally, 
our study and how it aims to further elucidate the role of Panx3 in bone formation is 
introduced.   
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1.5 Overview of Long Bone Growth and Development  
 
In mammals, bones form by one of two distinct processes during embryonic 
development. Intramembranous ossification is the process by which many of the 
craniofacial bones develop directly from condensations of mesenchymal cells. However, 
the long bones of mammals develop by a process of endochondral ossification whereby a 
precursor model made of hyaline cartilage first forms and is then replaced by bone. 
Endochondral ossification also enables longitudinal growth and healing of long bones 
(Ross and Pawlina 2011) .  
 
The transition from cartilage to bone is dependent on controlled chondrocyte and 
osteoblast differentiation. There are numerous molecules involved in an array of 
pathways that regulate the differentiation and behavior of these cells.  
 
The process of endochondral ossification begins with the aggregation of mesenchymal 
stem cells. Although all the molecular mechanisms required for this clustering of 
mesenchymal cells are not entirely understood, there are a number of elements involved 
in the process including adhesion molecules, the transcription factor SOX9, Hox proteins, 
fibroblast growth factors (FGFs) and bone morphogenic proteins (BMPs) (Long and 
Ornitz 2013) . Cells in the center of the aggregate differentiate into chondrocytes while 
those at the periphery form the perichondrium (Long and Ornitz 2013).  
 
Differentiation of chondrocytes is regulated by FGFs, and the transcription factors, 
SOX9, SOX5, and SOX6. As well, BMPs induce the differentiation of mesenchymal 
cells through SMAD protein signaling pathways (Long and Ornitz 2013). Chondrocytes 
secrete cartilage matrix (in hyaline cartilage the main matrix components are type II 
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collagen, glycosaminoglycans, proteoglycans and glycoproteins). Through the action of 
these components, the cartilaginous model of the bone is (Ross and Pawlina 2011).  
 
Chondrocytes proliferate and continue to secrete matrix resulting in growth of the 
cartilage model. Chondrocytes in the center mature, stop proliferating and hypertrophy. 
The hypertrophy of the chondrocytes is associated with secretion of type X collagen, 
matrix calcification, vascular invasion, and chondrocyte death followed by resorption of 
the calcified matrix and replacement by bone. The hypertrophied chondrocytes release 
alkaline phosphatase, an enzyme that is required for mineralization of the cartilage matrix 
(Fedde et al. 1999; Anderson 1969).  Hypertrophic chondrocytes secrete vesicles 
containing phosphates into columns of the matrix between rows of chondrocytes such 
that longitudinal septae are well calcified serving as scaffold for future bone deposition; 
the poorly calcified transverse partitions allow for subsequent infiltration of blood vessels 
(Amizuka et al. 2012).   Chondrocytes, now surrounded in calcified matrix, are restricted 
from nutrients and die.  This death results in breakdown of much of the matrix resulting 
in formation of a cavity. Concurrently, cells of the perichondrium in the mid region of the 
cartilage model differentiate into osteoblasts that secrete bone matrix resulting in 
formation of a bony collar in the diaphyseal region of the developing bone.  As well, 
vascular endothelial growth factor (VEGF) is released at the time of hypertrophy which 
attracts blood vessels into the center of the cartilage mold. The invasion of blood vessels 
brings osteoprogenitor cells which differentiate into osteoblasts and deposit bone matrix 
(osteoid) onto calcified cartilage spicules left behind by the death of the chondrocytes. In 
this way, trabecular bone is produced. Resorption of the calcified matrix driven by the 
appearance of proteolytic enzymes, most notably MMP13, and replacement with 
trabecular bone is stimulated. This initial site of bone formation in the center of the long 
bone is known as the primary ossification center (Ross and Pawlina 2011).  The cartilage 
matrix continues to be resorbed and haematopoietic stem cells arrive to form the marrow. 
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Between the newly generated bone and the cartilage of the epiphysis, the primary growth 
plate develops. Here, the maturing chondrocytes are arranged in distinctive zones. 
Furthest from the primary ossification center and nearest the epiphysis is the zone of 
resting chondrocytes. Moving toward the center of the diaphysis, the zones of 
proliferative, maturing, and hypertrophic chondrocytes are evident (White and Wallis 
2001; Ross and Pawlina 2011). Zones of calcified cartilage and resorption can also be 
identified toward the center of the diaphysis.  
 
In the resting zone, chondrocytes do not appear to proliferate or secrete matrix and 
probably serve as precursors for the proliferating chondrocytes in the adjacent, zone of 
proliferation (Kronenberg 2003). In the proliferative zone, chondrocytes divide, align in 
distinct columns, and secrete matrix constituents including collagen (mainly type II).  
Some studies identify a pre-hypertrophic zone, where chondrocytes enlarge and are in the 
process of maturing. Next to the pre-hypertrophic zone is the zone of hypertrophy, where 
chondrocytes are greatly enlarged. The hypertrophic chondrocytes remain active in 
secreting collagen (now increasingly type X) as well as VEGF and alkaline phosphatase.  
In the zone of calcified cartilage, the matrix becomes calcified and the hypertrophied 
chondrocytes begin to die. The zone of resorption is nearest the center of the diaphysis 
and is free of chondrocytes. Here, blood vessels invade and calcified cartilage forms 
spicules that serve as scaffold for the arriving osteoblasts to deposit new bone (Ross and 
Pawlina 2011).  
 
Secondary centers of ossification develop at proximal and distal ends of the bone 
(epiphyses) soon after birth. These ossification centers develop by the same process as 
the primary center whereby chondrocytes hypertrophy and degenerate, the matrix 
calcifies and blood vessels invade bringing osteogenic cells. In growing long bones, 
proliferating chondrocytes remain in the regions between each epiphysis and diaphysis 
(between the primary and secondary ossification centers) in the form of transverse 
cartilaginous discs known as the growth plates.  The bone lengthens as the chondrocytes 
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in the growth plates proliferate and secrete matrix, pushing the epiphysis further from the 
diaphysis. The cartilage is replaced by bone during growth by the same mechanism as 
during development. During growth, there is a balance between proliferation and 
resorption such that the thickness of the growth plate remains consistent. In humans, the 
growth plates fuse at puberty and longitudinal growth ceases at this time.   Radial growth 
is achieved through bone deposition by the cells of the periosteum. Although longitudinal 
growth ceases at puberty, bone remodeling continues throughout life.  
 
These processes of growth and remodeling, like development, are tightly controlled by 
both local and systemic factors. Systemic factors include growth hormone, estrogen, 
vitamin D, glucocorticoids and thyroid hormone. Locally produced factors include 
hedgehog proteins, FGFs, Wnts and BMPs (Kronenberg 2003) . Recent years have seen 
progress in understanding the role and interactions of these local factors in regulating 
bone growth and differentiation.  
 
1.6 Signaling Molecules Regulating Bone Growth 
 
1.6.1 Indian hedgehog and parathyroid hormone-related peptide 
regulate chondrocyte proliferation and differentiation  
 
Indian hedgehog (Ihh) is a signaling factor that is secreted by pre-hypertrophic and 
hypertrophic chondrocytes. Binding to its receptor, Patched-1 (Ptc) triggers a cascade 
leading to stimulation of chondrocyte proliferation. Ihh also indirectly inhibits 
chondrocytes from entering the hypertrophy stage by inducing the expression of 
parathyroid hormone-related peptide (PTHrP) (St-Jacques, Hammerschmidt, and 
McMahon 1999; Mackie et al. 2008).  
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PTHrp is a protein secreted by cells of the perichondrium and early proliferative 
chondrocytes; its receptor (the same G-protein-coupled receptor used by parathyroid 
hormone) is expressed at high levels by chondrocytes in the pre-hypertrophic zone.  Ihh 
binding to its receptor induces the production of PTHrP; binding of PTHrP to its receptor 
then delays chondrocyte hypertrophy through cAMP dependent signaling. Once cells 
have gone through hypertrophy they stop producing Ihh. PTHrP and Ihh form a negative 
feedback loop regulating chondrocyte entry into hypertrophy.  
 
Ihh is also necessary for differentiation of mesenchymal cells into osteoblasts for 
formation of the bony collar prior to formation of the primary ossification center and for 
osteoblast differentiation in both perichondrial cells and in the formation of trabecular 
bone.  In the absence of Ihh, perichondrial cells fail to express the transcription factor 
Runx2, which is necessary for osteoblast differentiation (Long and Ornitz 2013).  
 
1.6.2 Fibroblastic growth factor (FGF) regulates chondrocyte 
proliferation and differentiation 
 
There are 22 distinct genes encoding the structurally related FGF family of proteins and 
four genes encoding their receptors. FGF proteins and receptors are expressed at every 
level of endochondral ossification where they are involved in regulating chondrocyte 
proliferation and differentiation (Ornitz and Marie 2002). The fibroblast growth factor 
receptor-3 (FGFR3) is the best understood. Activation of this receptor inhibits 
chondrocyte proliferation and promotes hypertrophic differentiation of chondrocytes 
independent of other signaling systems (Minina et al. 2002). However, FGFR3 also 
exerts this effect by decreasing the expression of Ihh. Therefore, FGFR3 shortens the 
zone of proliferating chondrocytes by decreasing chondrocyte proliferation and by 
suppressing Ihh expression (Minina et al. 2002; Kronenberg 2003). 
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1.6.3 Bone morphogenetic protein (BMP) Signaling  
 
BMPs are another family of signaling molecules that are expressed at all stages of 
endochondral ossification. They are known to oppose the action of FGF in that they 
enhance the expression of Ihh and increase chondrocyte proliferation (Naski et al., 1998; 
Minina et al., 2002; Yoon et al., 2006). These antagonistic signaling systems demonstrate 
the importance of balancing interacting elements for proper bone development. BMP 
signaling is also important in promoting osteoblast differentiation and functioning.  
 
1.6.4 Transcription Factors: SOX9 and Runx2 
 
SOX9 is a transcription factor essential for chondrogenesis. It is expressed in the cells of 
mesenchymal condensations and in proliferating chondrocytes, but not in hypertrophic 
chondrocytes. Without SOX9, mesenchymal cells do not differentiate into chondrocytes 
and there is absence of cartilage and bone formation (Akiyama et al. 2002; Bi et al. 
1999). When Sox9 is deleted at later stages, most cells remain as mesenchymal 
condensations and do not differentiate into chondrocytes; there is also decreased 
expression of molecules of the Ihh-PTHrP pathways. As well, SOX9 is needed for 
expression of SOX5 and SOX6, other related transcription factors that act together with 
SOX9 for appropriate proliferation and timing of chondrocyte hypertrophy (Akiyama et 
al. 2002; Smits et al. 2004). Together the SOX transcription factors activate genes for 
components of the extracellular matrix and allow differentiation of progenitor cells into 
chondrocytes (de Crombrugghe et al. 2000; Long and Ornitz 2013; Smits et al. 2001). 
 
The transcription factor Runx2 has important roles in the growth plate where, along with 
Runx3 it promotes differentiation of chondrocytes from proliferative to hypertrophic and 
stimulates expression of Ihh (Yoshida et al. 2004). As well, it is required for osteoblast 
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formation and function (Otto et al. 1997; Komori et al. 1997).  Panx3 expression also 
appears to be regulated by Runx2 activity (Bond et al. 2011) . 
 
1.6.5 Wnt family of Proteins  
 
Members of the Wnt family of proteins are signaling molecules involved in the regulation 
of many biological processes (Alberts 2008). Wnts can activate three types of 
intracellular signaling pathways. One of these pathways, known as the canonical Wnt 
signaling pathway, is important in bone formation as it promotes osteoprogenitor 
proliferation and regulates bone mass (Glass et al. 2005). This pathway is dependent on 
the gene regulatory protein, Β-catenin (Alberts 2008). 
 
In the absence of Wnt, Β-catenin binds to a degradation complex that includes the 
scaffold protein, Axin, glycogen synthase kinase (GSK) and casein kinase 1 (CK1); once 
bound, Β-catenin is phosphorylated by CK1 and GSK which leads to Β-catenin 
degradation (Alberts 2008) .  When Wnt binds to a frizzled receptor, and the lipoprotein 
receptor-related protein (LRP) co-receptor, the scaffold protein, Dishevelled and Axin are 
recruited to the plasma membrane. The degradation protein complex is disrupted 
resulting in inhibition of Β-catenin phosphorylation. Therefore, in the presence of Wnt, 
Β-catenin accumulates in the cytoplasm and is then translocated to the nucleus. Here, it 
binds to transcription factors that activate transcription of proteins required for cell cycle 
progression as occurs in the proliferation stage of osteoprogenitor cells (Glass et al. 2005; 
Behrens et al. 1996; Alberts 2008).   
 
Protein kinase A (PKA), which is dependent on intracellular cAMP levels, positively 
regulates the Wnt pathway by phosphorylating and inactivating GSK, resulting in 
inhibition of Β-catenin degradation (Fang et al. 2000; Suzuki et al. 2008). As well, PKA 
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activates the cAMP-response element-binding (CREB) family of transcription factors 
which activates expression of genes for proliferation (Behrens et al. 1996).  
 
The PTHrP/PTH signaling pathway has a role in regulation of the Wnt pathway in that 
PTHrP/PTH binding to their receptor activates G proteins, which, in turn activate 
adenylyl cyclase to generate cAMP from ATP. Increased cAMP levels then increase 
activity of PKA. Subsequent activation of CREB then induces genes required for 
proliferation (in both chondrocyte and osteogenic cells) (Iwamoto et al. 2010). 
 
1.6.6 Role of Panx3 in Long Bone Growth and Development 
 
The current understanding of the role of Panx3 in bone biology is limited to in-vitro, and 
ex-vivo studies. It has been shown in these studies that Panx3 plays an important role in 
skeletal development as it promotes the switch from proliferation to differentiation in 
chondrocytes and osteoprogenitor cells (Iwamoto et al. 2010; Ishikawa et al. 2014). 
Evidence to date indicates that Panx3 has its effect on these processes by forming a 
channel that promotes the release of ATP into the extracellular space and by action as an 
ER calcium channel that allows for increased intracellular calcium (Iwamoto et al. 2010; 
Ishikawa et al. 2011; Ishikawa et al. 2014).  
 
1.6.7 Role of Panx3 in Chondrocyte Regulation 
 
As outlined above, endochondral ossification, the process by which long bones are 
formed, requires a skeletal template of cartilage. In the developing growth plate, 
chondrocytes organize into discrete zones according to their stage of maturation. 
Chondrocyte proliferation and differentiation must be spatially and temporally controlled 
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by the activity of numerous molecules and signaling systems for the formation of a 
healthy skeleton. Panx3 is implicated as one such molecule with an important role in the 
regulation of these processes.  
 
In endochondral ossification, Panx3 is first expressed by chondrocytes in the 
prehypertrophic zone of the developing growth plate (Iwamoto et al. 2010; Ishikawa et al. 
2011). Here, it forms channels that allow release of ATP from the interior of the cell to 
the extracellular space. Research has shown that this ATP release may lead to inhibition 
of the PTH/PTHrP signaling pathway that drives chondrocyte proliferation (Iwamoto et 
al. 2010).  
 
It is surmised that the Panx3 induced release of ATP out of the cell reduces intracellular 
cAMP levels, thus inhibiting PKA/CREB signaling which has the effect of down-
regulating proliferation. Panx3 expression also promotes the differentiation of 
chondrocytes from a proliferative to post-mitotic state (Iwamoto et al. 2010).    
 
1.6.8 Role of Panx3 in Osteoblast Regulation  
 
Panx3 is also expressed in osteoprogenitor cells and osteoblasts (Iwamoto et al. 2010; 
Ishikawa et al. 2011). Panx3 is induced during differentiation of osteogenic cells. 
Osteoblast marker genes are up-regulated and mineralization increased in cells over-
expressing Panx3 and these aspects of bone development are down-regulated in Panx3 
inhibited cells, indicating a role for Panx3 in promoting differentiation of osteoblasts 
(Ishikawa et al. 2011).  
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Calcium is known to be involved in many signaling pathways, including the calcium-
calmodulin system that promotes osteoblast differentiation (Zayzafoon, Fulzele, and 
McDonald 2005; Seo et al. 2009). Panx3 was localized to the plasma membrane and was 
co-localized with a marker of the endoplasmic reticulum (ER), an organelle that stores 
calcium, suggesting Panx3 is localized in the ER (Ishikawa et al. 2011). Panx3 over-
expressing osteoprogenitor cells that were stimulated by ATP demonstrated increased 
intracellular calcium levels. As well, Panx3 transfected cells showed increased activity of 
calcium-calmodulin and increased levels of downstream proteins in this pathway 
(Ishikawa et al. 2011). 
 
Panx3 expression reduced intracellular ATP and increased extracellular ATP. 
Extracellular ATP can bind to purinergic receptors that initiate signaling pathways that 
activate ER calcium channels. Evidence suggests that the Panx3 ER calcium channel is 
activated when this purinergic binding activates the P13K-Akt pathway, a mechanism 
distinct from that of other ER calcium channels. (Ishikawa et al. 2011).   
 
Calcium binding to calmodulin can then activate molecules downstream that promote 
osteoblast differentiation (Seo et al. 2009). Increased calcium also initiates signaling 
cascades that promote degradation of p53, an inhibitor of differentiation (Ishikawa et al. 
2011) and that increase protein levels and activation of p21, a protein that promotes cell 
cycle exit (Ishikawa et al. 2014). Thus, Panx3 promotes osteoblast differentiation by 
functioning as a plasma membrane channel releasing ATP and by acting as an ER 
channel that increases intracellular calcium signaling. 
 
Some signaling pathways important in osteoprogenitor proliferation and differentiation 
have been identified. However, understanding regarding the regulation of these signaling 
pathways and the mechanism by which osteoprogenitors transition from proliferation to 
differentiation remains incomplete. Panx3 appears to have a key role in this transition by 
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inhibiting osteoprogenitor proliferation and promoting cell cycle exit through several 
signaling pathways (Ishikawa et al. 2014). 
 
Osteoprogenitor proliferation and bone mineralization are promoted by the canonical Wnt 
signaling pathway (Glass et al. 2005; Kato et al. 2002; Ishikawa et al. 2014). It has been 
shown that Panx3 expression inhibits osteoprogenitor proliferation and promotes cell 
cycle exit (Ishikawa et al. 2014). Exogenous Wnt has the effect of increased cell 
proliferation in normal osteoprogenitor cells. However, proliferation is inhibited in Panx3 
over-expressing cells despite the addition of exogenous Wnt. Localization of Β-catenin to 
the nucleus is decreased and phosphorylation of Β-catenin is increased in Panx3 over-
expressing cells whereas phosphorylation of GSK3 is inhibited (Ishikawa et al. 2014).  
 
Panx3 is induced by BMP prior to mineralization (Bond et al. 2011; Ishikawa et al. 
2014). Panx3 channels promote release of ATP from the cell to the extracellular space; 
this movement of ATP initiates multiple Panx3 signaling pathways that act to inhibit 
proliferation of osteoprogenitor cells and to promote cell cycle exit (Ishikawa et al. 
2014). Release of ATP decreases the amount of cAMP that can be produced in the cell. 
PKA, when activated by cAMP, functions to phosphorylate and inhibit GSK3. As cAMP 
is reduced upon Panx3 expression, the action of PKA is reduced and GSK3 activity is 
increased. Therefore, Β-catenin is phosphorylated and degraded and there is reduced 
transcription of genes necessary for proliferation.  
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2 INTRODUCTION 
 
2.1 Pannexin 3 and Long Bone Biology 
 
Taken together, current evidence supports the involvement of Panx3 in multiple signaling 
pathways required for appropriate skeletal development and growth. These pathways are 
induced when Panx3 single membrane channels promote release of ATP from the cell to 
the extracellular space. The increased extracellular ATP has the effect of activating 
purinergic receptors initiating the P13K-Akt pathway and other purinergic regulated 
pathways for ER calcium release leading to subsequent activation by calcium of signaling 
cascades that promote cell cycle exit and promote differentiation.  As well, ATP release 
reduces intracellular cAMP levels leading to inhibitory regulation of Wnt and PKA-
CREB pathways required for cell proliferation. Therefore, Panx3 plays an important role 
in bone formation by inhibiting cell proliferation and promoting chondrocyte and 
osteoblast differentiation; these regulatory processes are required for bone growth and 
mineralization.  
 
2.2 Shape Differences 
 
To examine the morphology of the long bones of Panx3 KO mice and compare the 
phenotype to that of WT mice, a quantitative shape analysis approach was used.  This 
quantitative approach to shape comparison is a branch of statistics known as geometric 
morphometrics. It describes a set of methods used to analyze landmark coordinate data 
using multivariate statistics.   A landmark is a point in two or three-dimensional space 
corresponding to a feature of interest on an object (Zelditch, Swiderski, and Sheets 2012). 
Landmark analysis is always multivariate in that a shape is described by a configuration 
of landmarks and cannot be described by a single point. 
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The benefits of using landmark coordinate data when performing shape comparisons 
include preserving information about spatial relationships between points and preserving 
the original geometries of the forms. Therefore, landmarks allow us to elucidate 
information about the nature and location of differences.  Landmark analysis also allows 
for easy visualization and communication of shape differences among complex forms 
while still providing a quantitative and precise description.  It allows for statistical 
analysis of the average form as well as variation about the average (Frelat et al. 2012).  
Landmark data are also superior in detecting subtle or complex shape differences that can 
be common when comparing specimens of the same species (Baab, McNulty, and Rohlf 
2012). Another strength of landmark data analysis is that it allows for a separation of 
shape variation from total size variation and allows for investigation of the relationship 
between size and shape (Baab, McNulty, and Rohlf 2012). A limitation of this type of 
landmark coordinate data is that it does not describe the curvatures of a form. It is also 
not always possible to find evenly spaced landmarks, so that there may be more 
landmarks in one area of a form than in another. 
 
By examining the localized shape differences between long bones of KO vs WT mice, it 
may be possible to identify those areas most affected by Panx3 and therefore identify 
those processes most affected.  Findings may direct future investigation into as yet 
unknown mechanisms regulating normal and pathological bone development. 
 
2.3 Cross-Sectional Geometry  
 
Long bone shape and size reflect not only their genetic and developmental history, but 
also reflect adaptations to their mechanical environment over time (Lieberman, Polk, and 
Demes 2004). The cross-sectional geometric properties of a long bone are aspects of 
structural variation that can be used to predict the mechanical performance of the bone 
under applied forces and assess “loading history” or mechanical adaptations of the bone 
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(Lieberman, Polk, and Demes 2004). This type of analysis has been useful in fields such 
as orthopaedics where mechanical performance is of great clinical significance (Burstein 
and Wright 1994) and in anthropological research where it has allowed for inferences 
about the behavior and lifestyle of extant populations based on skeletal remains 
(Katzenberg and Saunders 2008).  
 
These applications are possible due to the propensity of living skeletal tissues to respond 
to application of mechanical forces by way of adaptations that influence their 
morphology. This premise that mechanical loading of bone results in structural changes 
of the bone is often referred to as “Wolff’s Law”, named after the 19th century 
orthopaedic surgeon who popularized the concept. However, in its original form, Wolff 
intended to formulate strict mathematical rules to describe the process and the concept 
may better be described today as “bone functional adaptation” to mechanical loading 
(Katzenberg and Saunders 2008; C. Ruff, Holt, and Trinkaus 2006). 
 
Bone functional adaptation can most simply be described by a feedback model of bone 
adaptation where bone deposition / resorption is stimulated based on maintaining an 
“optimum customary level” of strain. Strain is the physical deformation of the bone tissue 
under force and as strain increases, such as when activity levels increase, there is net 
bone deposition thereby restoring the original amount of strain. When strain decreases 
beyond a set-point, bone is resorbed to restore original levels (Katzenberg and Saunders 
2008; Sumner-Smith and Bishop 1982; C. Ruff, Holt, and Trinkaus 2006). The 
“customary level” of strain, however, can vary according to skeletal location and 
systemic factors such as age, disease, diet, hormonal factors and genetics (Katzenberg 
and Saunders 2008; Lieberman, Devlin, and Pearson 2001; C. Ruff, Holt, and Trinkaus 
2006; Pearson and Lieberman 2004). The frequency and type of strain, and loading 
history of the bone are other variables that influence the response of bone to its 
mechanical environment (Burr, Robling, and Turner 2002; C. Ruff, Holt, and Trinkaus 
2006). 
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Support for this optimum strain model of functional adaptation come from animal studies 
(Burr, Robling, and Turner 2002; Robling et al. 2002; Woo et al. 1981; C. Ruff, Holt, and 
Trinkaus 2006) that demonstrate the response of bone to loading is to preferentially 
increase deposition of bone in areas of greatest strain. As well, improved resistance in 
exercised bone appears to have little to do with bone mineral density or the quality of 
bone, which changes little, but can instead be attributed to increases in the quantity and 
distribution of bone; these characteristics are represented by the geometric properties of 
the bone (Burr, Robling, and Turner 2002; Robling et al. 2002; C. Ruff, Holt, and 
Trinkaus 2006; Woo et al. 1981).  
 
The engineering concept of beam theory whereby properties of strength and rigidity of a 
beam can be calculated given the geometrical properties of the structure can be applied to 
a long bone. A long bone diaphysis can be considered as behaving like a hollow beam 
when mechanical loads are applied (Huiskes 1982; Katzenberg and Saunders 2008; C. B. 
Ruff and Hayes 1983).In beam theory, “strength” refers to the maximum amount of stress 
(force per unit area) a structure can sustain prior to failure; (Reilly and Burstein 1974). 
“Rigidity” is a measure of a structure’s resistance to deformation under externally applied 
forces. Strength can be thought of as a structure’s ability to resist breaking and rigidity as 
a structure’s ability to remain stiff and resist bending (Katzenberg and Saunders 2008).  
 
Different types of mechanical stresses can affect a beam structure. Axial compression and 
tension act along the long axis to compress or stretch the material respectively. Bending 
creates compressive and tensile forces on opposite sides of a cross-section; torsion refers 
to twisting about the long axis which produces shearing (diagonal) forces (Katzenberg 
and Saunders 2008).   
 
Cross-sectional geometric properties of a bone can be used to quantify the strength and 
rigidity of a bone in relation to these different kinds of mechanical loadings.  Cross-
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sectional area of a beam reflects the beam’s resistance to pure compression and tension 
(loads applied along the long axis which is perpendicular to the cross-section); in a long 
bone, the cross-sectional area is equal to the cortical area, denoted, CA. However due to 
the curvature of bones and the direction of muscle pull, among other factors, bones are 
rarely subjected to purely axial loads. Most often, bones are subjected to bending and 
torsion that describe bending about a particular axis (C. B. Ruff and Hayes 1983; 
Katzenberg and Saunders 2008). These more relevant mechanical loadings are 
proportional to cross-sectional geometric properties known as second moments of area.   
 
Second moments of area are the product of unit areas of material and the squared 
distances of these areas to the axis in the plane of bending (units are mm
4
). Therefore, 
both the total area of material and its distribution about a defined axis are included in this 
measure. Second moments of area can be calculated about any axis through the section 
depending on the direction of the applied bending force and are designated, I, with a 
subscript indicating the axis about which they were calculated. They are usually 
calculated about anatomical axes (mediolateral and anteroposterior) or as maximum and 
minimum (Imax and Imin). Imax and Imin are always orthogonal to each other and indicate the 
magnitudes of the greatest and least bending rigidities of the section respectively.  
 
Second moments of area calculated about the central point (centroid) of the section or the 
sum of any two perpendicular measures of I (eg. Imax + Imin), are known as polar second 
moments of area, designated, J, and describe the structure’s resistance to torsion as well 
as the average bending rigidity. Therefore, J is the most important cross-sectional 
geometric property for describing a bone’s overall rigidity (C. B. Ruff and Hayes 1983; 
Lieberman, Polk, and Demes 2004).  
 
Upon application of bending or torsional forces, maximum stress occurs at the outermost 
surface of the cross-section. Therefore, bone tissue that is distributed further from the 
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centroid will provide more resistance to bending and torsional forces (Bertram and 
Swartz 1991).  To provide an index of “strength”, second moments of area are divided by 
the distance from the outermost surface to the neutral axis (0 strain) for bending or to the 
centroid for torsion.  This property is referred to as section modulus, Z.  
 
However, in the absence of experimental strain data, J has proven the most accurate 
estimate of a bone’s average bending rigidity (Lieberman, Polk, and Demes 2004). Z 
compounds errors associated with deviation of bending axes from the centroid in-vivo 
due to unpredictable factors such as changes in ground surface, limb positioning, and 
muscle forces involved (Lieberman, Polk, and Demes 2004; C. Ruff, Holt, and Trinkaus 
2006).  
 
Due to such complexities, calculations of cross-sectional properties from long bone 
geometry are approximations of in-vivo bone rigidity and strength and there is 
considerable error (30-50%) involved regarding absolute values (Lieberman, Polk, and 
Demes 2004; C. Ruff, Holt, and Trinkaus 2006). However, these calculations remain 
valid indicators of mechanical performance when used for comparison of relative in-vivo 
properties for the same bone within a species or between similar species where loading 
patterns are similar (Lieberman, Polk, and Demes 2004; C. Ruff, Holt, and Trinkaus 
2006).  
 
2.3.1 Bone Shape 
 
The mechanical performance of a bone is a function of both the amount of tissue and the 
distribution of that tissue. Therefore, not only do the size and mass of a bone contribute to 
its rigidity, so does its shape determine these properties. In anthropological studies of 
fossilized remains, it is theorized that differences in the massiveness of long bone 
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diaphyses between populations reflect varying levels of activity whereas differences in 
shape reflect alternate patterns of activity (Trinkaus et al. 1991). Support for this theory 
comes from animal studies (Carlson and Judex 2007; Nunamaker, Butterweck, and 
Provost 1990) and studies of human athletes (Shaw and Stock 2009a; Shaw and Stock 
2009b; Macdonald, Cooper, and McKay 2008) that demonstrate changes in diaphyseal 
shape that reflect adaptation to specific mechanical loading patterns and overall increases 
in cortical bone related to increased activity levels.  
 
Quantification of diaphyseal cross-sectional shape for use in comparisons is 
accomplished using Imax/Imin. This ratio estimates the distribution of cortical bone relative 
to the centroid. Imax and Imin are a function of the distribution of tissue in the section and 
therefore provide a better measure of shape than any other ratio of second moments of 
area (Shaw and Stock 2009b).  It is also of note that this ratio can be used to judge the 
reliability of J as an accurate indicator of rigidity. As the section departs from circularity, 
the reliability of J as an index of rigidity decreases (Daegling 2002; Shaw and Stock 
2009b). 
 
2.3.2 Other Cross-Sectional Properties 
 
Other values obtained from analysis of cross-sectional geometry are useful as descriptors 
of a bone’s morphology. The total subperiosteal area, denoted TA, is the total area within 
the bone’s perimeter and the medullary area is denoted MA and it is the area of the 
medullary canal. These qualities also describe the relative distribution of bone in a 
section. The percent cortical area calculated CA/TA X 100 is another descriptor of 
cortical thickness and the relationship of tissues in the section (Katzenberg and Saunders 
2008).   
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2.4 Objectives and Rationale 
 
Despite the crucial role that Panx3 plays in bone development, there are no overt 
phenotypic effects of knocking out Panx3 in a mouse model (Moon et al. 2015). While 
the role of Panx3 in bone development has been studied in cultured cells, it has not been 
systematically explored in vivo. Additionally, the apparent contradiction between the key 
role of Panx3 in bone development, and the lack of gross phenotypic effects upon 
ablation of the protein remains unexplained.  To begin to address the paucity of 
understanding in these areas, and help uncover the role of Panx3 in physiological 
processes, a novel Panx3 knockout (KO) mouse line was used. This mouse globally lacks 
Panx3 in all tissues.  
 
In this study, the phenotypic aspects of long bones in KO and WT mice were compared 
to further elucidate the role of Panx3 in bone formation.  Specifically, the study quantifies 
and compares the shape, size, bone mineral density and cross-sectional geometric 
properties of the femur and humerus between KO and WT mice. 
 
2.5 Hypothesis 
 
It is hypothesized that Panx3 KO mice will demonstrate differences in long bone shape 
(greatest at the growth plates), with decreased size, decreased bone mineral density, and 
indexes of decreased mechanical performance when compared to WT controls.  As well, 
greater variability is expected in KO than WT mice.   
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3 METHODS 
 
3.1 Animals 
 
The sample consisted of 10 adult wildtype and 10 adult Panx3 knockout mice. Panx3 KO 
mice were obtained that had been generated using embryonic cells with a C57BL/6N 
origin and using the Cre/IoxP recombinase system (Moon et al. 2015). WT mice were 
C57BL/6 non-littermate controls.  
 
All mice were male and were 2 or 3 months of age at the time of scanning. Two KO mice 
and 4 WT mice were 3 months old at the time of scanning and all other mice were 2 
months of age.  At the time of scanning, the average weight of WT mice was 26.3 grams 
and the average weight of KO mice was 24.6 grams. There was no significant difference 
in weight between the two groups at the time of scanning (p = 0.14; Figure 8).  
 
3.2 Micro-computed Tomography Imaging  
 
High resolution micro-computed tomography (µCT) whole body images of the mice were 
obtained using the eXplore speCZT µCT scanner (GE Healthcare, Waukesha, WI, USA) 
at Robarts Research Institute (London, ON, Canada). Mice were anesthetized through 
face-cone administered isofluorane (Forane, catalog #CA2L9100, Baxter Corporation, 
Mississauga, ON Canada) and imaged using in-vivo scanning techniques following 
Granton and colleagues (2010). In one rotation of the beam, 900 views were obtained at 
0.40 intervals over a 5 minute period (16ms exposure). Images were acquired at isotropic 
voxel size of 50 µm and reconstructed into 3D volumes at 100 µm to reduce noise 
associated with breathing. Two separate scans were required to capture the whole mouse. 
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The two scans were later digitally ‘stitched’ together to render a full 3D volume of the 
entire mouse.  Total scan time per animal was 10 minutes. Calibration samples of water 
and a synthetic cortical-bone mimicking epoxy with a bone mineral equivalent of 1,100 
mg/cm3 (SB3, Gamex, Middleton, WI, USA) were imaged in a separate scan to ensure 
accurate calibration of CT greyscale intensities in Hounsfield Units (HU).  
 
3.3 Segmentation 
 
Reconstructed images were then examined using MicroView. Right femora and humeri 
were isolated from the whole body images by manually segmenting each bone using 
MicroView.  
 
3.4 Landmark-Based Data Collection and Analyses 
Methods 
 
3.4.1 Choosing Landmarks 
 
When choosing landmarks, criteria of homology, adequate coverage and repeatability 
were considered. Three-dimensional coordinates were recorded for each specimen 
(Figure 2; Figure 3).For biological and mathematical purposes, the most important 
criterion is that of homology (Zelditch, Swiderski, and Sheets 2012). Here, the term 
homologous refers to choosing landmarks as discrete points that can be recognized as the 
same anatomical loci on all specimens (Zelditch, Swiderski, and Sheets 2012). The 
position of each 3-dimensional landmark is then recorded as a set of x-, y-, and z-
coordinates. 
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As much as possible, landmarks were also chosen to provide adequate coverage of the 
form. However, it is noted that landmarks could not be chosen over the articulating joint 
surfaces as manual segmentation of the bones from their joint did not allow for a clean 
outline of these surfaces. Landmark repeatability was tested empirically by performing 
repeat measurements and discarding those landmarks that were not reliably repeatable. 
 
3.4.2 Landmark Acquisition 
 
The software package, etips (a multidimensional volume visualization and analysis 
software co-developed by the NIH and the National University of Singapore) was used to 
reconstruct surface representations of the segmented right femur and right humerus from 
each mouse. Landmarks were then taken from these reconstructions. To determine 
suitability of landmarks, for the femora and then the humeri, 4 bones were digitized 4 
times. Points that could be repeated within 0.05mm of error were deemed acceptable 
(Frelat et al. 2012).  
  
3.4.3 Femur Sample 
 
Fourteen, three-dimensional landmarks were collected from the right femur of each 
mouse in the study (n=18). Femora from two mice (one WT and one KO) were not used 
due to movement artifacts that prevented accurate landmark collection. Each femur was 
digitized twice and the averaged coordinate data were used for subsequent analyses. All 
data were screened for outliers.  
 
28 
 
Table 1.  List of Femoral Landmarks (Figure 2) Used in this Study and their 
Anatomical Description. 
Femoral Landmarks 
Landmark  
Number 
Landmark 
Identifier 
Description of Landmark Location  
   
1 in Intercondylar fossa 
2 gts Tip of greater trochanter 
3 gtp Tip of third trochanter 
4 ditc Distal intertrochanteric crest 
5 pitf Point of greatest curvature of longest arm of third 
trochanter 
6 gtl Anterior corner of greater trochanter  
7 ptt Proximal end of third trochanter 
8 dtt Distal end of third trochanter 
9 ltsd Distal end under lesser trochanter on shaft  
10 tgta Line where third trochanter meets greater trochanter 
11 lep Lateral epicondyle 
12 lps Lateral aspect of superior tip of patellar articular 
surface 
13 mps Medial aspect of superior tip of patellar articular 
surface 
14 mep Medial epicondyle 
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Figure 2. Mouse femur in rostral view (above) and caudal view (below) with the 14 
landmarks used in this study superimposed. 
 
3.4.4 Humerus Sample 
 
The right humerus from each mouse (n=20) was digitized twice using 12, three-
dimensional landmarks. The average coordinates for each landmark were used for 
analysis. All data were screened for outliers. 
 
 
 
 
 
30 
 
Table 2. List of Humeral Landmarks (see Figure 3) Used in this Study and their 
Anatomical Description. 
Humeral Landmarks 
Landmark  
Number 
Landmark 
Identifier 
Description of Landmark Location  
   
1 ins Superior point on proximal growth plate in between 
greater and lesser tubercle 
2 pgp Superior point on proximal growth plate lateral view 
3 mltgp Medial side greater tubercle meets proximal growth plate 
4 lgtgp Lateral side tubercle meets growth plate 
5 hlt Between head of humerus and lesser tubercle at level of 
growth plate 
6 pdt Proximal deltoid tuberosity 
7 tdt Tip of deltoid tuberosity 
8 ddt Distal deltoid tuberosity 
9 lep Lateral epicondyle 
10 sc Supinator crest (most lateral point) 
11 cf Olecranon fossa 
12 mep Medial epicondyle 
        
                           
Figure 3. Mouse humerus in rostral view (above) and caudal view (below) with the 12 
landmarks used in this study superimposed. 
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3.5 Analysis 
 
3.5.1 Shape and Size  
 
In analysis of landmark data for this study, principal components analysis (PCA) was first 
used to investigate and visualize patterns in the data. Euclidean Distance Matrix Analysis 
(EDMA) (Lele and Richtsmeier 2001) was then used to quantify and localize differences. 
Investigation for differences in variances of interlandmark distances was statistically 
evaluated with a bootstrap approach using MIBoot (Cole, 2002). 
 
3.5.2 PCA 
 
To simplify the description of variation in the sample and allow for better visualization 
and interpretation of the distribution of that variation in a small sample size, PCA was 
used.  All bones included in the study as defined by 14 landmarks (femur) or 12 
landmarks (humerus) were superimposed by means of a general Procrustes analysis 
whereby landmark configurations are translated, rotated and scaled so as to minimize the 
squared distances between corresponding landmarks (Rohlf and Slice 1990). The 
resulting Procrustes coordinates were analyzed by PCA.  
 
PCA finds the axes of greatest variation in the dataset; principal component 1 (PC1) is 
the line through the data that accounts for the largest amount of variation, and each 
successive axis is orthogonal to previous axes and explains a successively smaller 
proportion of the variation (Richtsmeier et al. 1998; Zelditch, Swiderski, and Sheets 
2012). Most of the variation is explained in the first two principal components, thereby 
reducing the number of variables that need be viewed. A score is determined for each 
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individual of the sample that represents its distance from the mean of the sample. These 
principal component scores allow each individual to be plotted on the principal 
coordinate axes.  The relative positions of the data points remain the same and we can see 
how individuals group relative to each other and in terms of the axes that describe most 
of the variation in the sample. 
 
This type of analysis is appropriate for statistical comparisons with smaller sample sizes 
where there are many variables and few specimens, as reducing the number of variables 
that need be considered allows us to increase the statistical power and detect meaningful 
differences (Zelditch, Swiderski, and Sheets 2012).  PCA analysis on Procrustes 
coordinates allows for comparison of the overall shape and size of the long bones while 
maintaining the relative geometry of landmarks (Zelditch, Swiderski, and Sheets 2012) 
(For a more in depth discussion of PCA, see Appendix A).  
 
3.5.3 Euclidean Distance Matrix Analysis (EDMA) 
 
While PCA is useful for simplifying and describing the variation in an overall form, it is 
also beneficial to consider localized shape differences. As well, Procrustes based analysis 
assumes a normal distribution of variance, limiting its use with a small sample size in 
analyses other than PCA.  
 
Another approach, Euclidean Distance Matrix Analysis (EDMA), is a non-parametric 
landmark analysis method that allows for statistically consistent results even with a small 
sample of specimens (Richtsmeier et al. 1998). EDMA also allows visualization of how 
differences are localized. In this analysis, comparison of aspects of form and shape does 
not depend on an arbitrary choice of a common coordinate system or on the variance 
about a point. Therefore, the aspects considered in the comparison do not vary with 
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translation, rotation or reflection of the object (Lele and Richtsmeier 2001). This 
approach is based on distances between landmark pairs and quantifies differences using 
matrix algebra (Lele and Richtsmeier 2001).  
 
Therefore, landmark data was further analyzed using EDMA. To accomplish this 
analysis, the landmark coordinates were used to calculate all possible linear distances 
(Euclidean distances) between landmark pairs. A matrix consisting of these distances is 
known as the form matrix (FM) and represents the individual specimen.  An average FM 
is then determined for each group. The average form matrix from each group is compared 
and the difference between forms is expressed as a form difference matrix (FDM). 
Elements of the FDM correspond to the ratios (division of an element in one form matrix 
by its corresponding element in the other form matrix) of the linear distances. 
 
To account for size differences, the geometric mean of all distances can be used as a 
scaling factor to create a shape matrix (Lele and Richtsmeier 2001). The outcome is size-
corrected forms that, when compared, are considered a comparison of shape. The mean 
shape difference matrix represents the shape difference between sample groups. The 
elements of the shape difference matrix correspond to the difference between like linear 
distances of the two shape matrices. For a more in-depth discussion of EDMA, see 
Appendix B. 
 
3.5.4 Use of Confidence Intervals for Statistical Comparison of 
Localized Differences 
 
The estimated form difference matrix can determine if a particular distance is larger in 
one group than in the other. To determine if the difference in the interlandmark distance 
is statistically significant, confidence intervals are used (Lele 1995; Lele and Richtsmeier 
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2001). To obtain the confidence intervals, a Bootstrap approach is used. This approach 
involves random sampling with replacement. The bootstrap simulates what might happen 
if the experiment were repeated many times over with more individuals. A random 
sample of the landmark coordinate matrices representing individuals is taken from each 
group with replacement. The mean form difference matrix is then calculated for the 
samples obtained. These steps are repeated 1000 times.  
 
As introduced by Lele and Richtsmeier (1995), a confidence interval is obtained for each 
interlandmark distance by sorting the obtained ratios. If the interval between the upper 
and lower confidence limits contains the value 1, then it is likely that this particular 
distance is not different in the two groups when comparing form. (When comparing 
shape, if the interval contains the value 0 then the distances are likely not different). The 
interval also provides an idea as to the magnitude of the difference between groups for a 
particular distance. This type of analysis is appropriate for small sample sizes as it 
removes the sample size constraints of parametric statistics. 
 
3.5.5 Shape Variance 
 
To compare the differences in variances of interlandmark distances between groups, and 
to statistically evaluate these differences using a bootstrap approach, the Windows-based 
software package, MIBoot was used (Cole 2002).  
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3.6 Bone Mineral Density (BMD) 
 
MicroView software (GE Healthcare Biosciences) was used to calculate bone mineral 
density (BMD) where BMD is the ratio of the average HU value of the bone region under 
examination to the measured HU value of the SB3 calibrator (Beaucage et al. 2014).  The 
difference in BMD between groups was tested for significance using a Welch’s two-
sample t-test and a Wilcoxon rank sum test in R statistical computing environment.  
 
3.7 Cross-Sectional Geometric Properties 
 
3.7.1 Data Collection  
 
Segmented bones were aligned in MicroView and 100 micron slice thickness cross-
sections obtained orthogonal to the long axis of each bone. Due to movement artifact, two 
WT and two KO mice were excluded from cross-sectional geometric analyses. 
Diaphyseal cross-sectional locations were determined based on percentages of bone 
length. Cross-sections were obtained at 50% of bone length for the femur and at 40% of 
bone length measured from the distal end for the humerus (to avoid the deltoid 
tuberosity). Similar cross-sectional locations have been used in previous studies assessing 
long bone diaphyseal mechanical performance (Ruff 2002).  
 
The cross-sectional scans were then imported into the ImageJ (NIH) and a consistent 
density threshold to represent bone was set. MomentMacro, a plugin for ImageJ was used 
to calculate cortical bone area (CA), total subperiosteal area (TA), second moments of 
area (Imax, Imin) and second polar moment of area (J). Obtained values were used for 
further calculations of Imax/Imin, and percent cortical area (%CA) (see Table 4).Cross-
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sectional geometric properties were statistically compared using Welch’s t-tests and 
Wilcoxon rank sum test using R statistical environment.  P-values were adjusted for 
multiple tests using the Bonferroni correction.    
 
3.8 Standardization 
 
When comparing the structural and mechanical properties of bone amongst individuals, 
body size and limb proportions must be considered as these characteristics influence 
mechanical loading and skeletal mass. There is the general acceptance that measures of 
cross-sectional area are best standardized using body mass and that second moments of 
area are standardized using the product of body mass and bone length (ie moment arm) 
(Katzenberg and Saunders 2008; Stock and Shaw 2007).  
 
Therefore, to control for any variation in body size, second moments of area (Imax, Imin) 
and polar second moments of area (J) were standardized by the product of body mass and 
bone length
2
. Cortical area (CA) and total subperiosteal area (TA) were standardized by 
body mass. The following standardization formulas were used: J/(Body Mass X Length
2
); 
CA/Body Mass; TA/Body Mass; Imax/(Body Mass X Length
2
); Imin/(Body Mass X 
Length
2
).  TA is the total subperiosteal area and %CA is CA/TA X 100.  
 
Full-length bone measurements were performed in MicroView.  Femur length was 
measured as the distance from the most superior point of the greater trochanter to the 
most inferior point of the distal epiphysis and humerus length was measured from the 
greater tubercle to the distal epiphysis.  
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4 RESULTS 
 
4.1 Size and Shape of Long Bones  
 
4.1.1 Principal Components Analysis 
 
Differences between WT and KO mice were compared using Principal Components 
Analysis (PCA) in MorphoJ. In the PCA analysis, a regression on age was first performed 
and residuals used for subsequent analysis in order to remove any effect of age on shape.  
 
Femoral and humeral shape as determined by the first two principal components are 
depicted in scatterplots in Figure 4. Within the femur, PC1 accounts for 40% of the total 
variance, PC2 accounts for 16% of the variance, and PC3 accounts for 10% of the 
variance.  For the humerus, 57% of the total variance is represented by PC1, 10% is 
represented by PC2, and 7% of the variance is represented by PC3. Thus, the majority of 
variance is represented by the first two principal components.  This analysis shows that 
the shape of KO and WT femora and humeri are differentiated along PC1 as shown in 
Figure 4 (A, B). 
 
Femoral and humeral shape with the allometric component removed as determined by the 
first two principal components are depicted in scatterplots in Figure 4 (C, D).  In the 
femur, PC1 accounts for 30% of the total variance, PC2 accounts for 18% of the variance 
and PC3 accounts for 11% of the variance. For the humerus, 40% of the total variance is 
represented by PC1, 15% by PC2, and 10% by PC3 when the size component of shape is 
removed. When the allometric component of shape is removed (regression of shape on 
size), there is no distinct separation of the groups (Figure 4 (C, D)). These groupings 
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demonstrate that much of the difference between WT and KO bone shape is attributable 
to a difference in their size proportions.  
 
Performing a regression of shape on size separates the component of variation that is 
predicted by size from the residual component of variation. Using the residuals from this 
regression, Morpho J calculates the percentage of total shape variation that is due to size 
variation. When this analysis is carried out on the femur data, centroid size accounts for 
20% of the total shape variance among individuals. Permutation testing against the null 
hypothesis of independence between shape and size variables was also performed. The 
null hypothesis was rejected and it is indicated that size accounts for a significant portion 
of the femoral shape difference between groups (p < 0.01).  
 
For the humeri, the allometric component of shape accounts for 30% of the total shape 
variance among individuals. A permutation test determined that the allometric component 
of shape accounts for a statistically significant proportion of total shape variation (p < 
0.01). 
 
Thus, PCA demonstrates that KO femora and humeri shape differs from that of WT mice 
and that a significant portion of the overall shape difference is due to allometric 
differences. 
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Figure 4. Scatterplots of the first two principal components for the femur and humerus with (A, B) and without (C, D) the allometric 
component of shape.  WT and KO humeral and femoral shape are differentiated along PC1 when the allometric component of shape is 
included (A, B).
A 
B 
C 
D 
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4.1.2 EDMA Analysis 
 
4.1.2.1 Form Difference Results 
 
Form analysis of the femur reveals that 17/91 (19%) distances are larger in KO than in 
WT. However only 1 of those distances is significantly greater (in – lep). The vast 
majority of distances, 74/91 (81%), are greater in WT than in KO; 45 of these distances 
(49%) are significantly greater in WT than in KO mice.  
 
Form analysis of the humerus reveals that 12/66 (18%) distances are greater in KO than 
in WT. However, none of these distances are significantly greater. The majority of 
distances, 54/66 (82%), are greater in WT than in KO; 34 of these distances (51%) are 
significantly greater in WT than in KO mice.  
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Figure 5. Femoral (A-C) and humeral (D-F) linear distances that are significantly different 
in form between WT and KO mice as determined by confidence interval testing. Distances 
that are greater in WT than KO by at least 5% are drawn in blue.  The distance that is 
significantly greater in KO than in WT is drawn in pink. (A) rostral , (B) caudal, (C)  
supero-rostral views of the mouse right femur. (D) rostro-medial, (E) caudal, (F) supero-
medial views of right humerus. 
 
A 
B 
C 
D 
E 
F 
WT greater than KO by intervals of 5-10% to 7-13% 
KO greater than WT 1-8% 
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4.1.2.2 Shape Difference Results 
 
Shape analysis of the femur reveals that 41/91 (45%) distances are larger in KO than in 
WT. Of those distances, 13 (14%) are significantly greater in KO than in WT mice. 
Approximately half of the distances, 48/91 (53%), are greater in WT than in KO.  Of 
these distances, 38 (42%) are significantly greater in WT than in KO mice.  
 
Shape analysis of the humerus reveals that 36/66 (54%) distances are greater in KO than 
in WT; 22 (33%) of the distances are significantly greater in KO than in WT mice. 30/66 
(45%) distances are greater in WT than in KO; 25 (38%) of the distances are significantly 
greater in WT than in KO mice. 
  
43 
 
               
 
Figure 6. Femoral (A-C) and humeral (D-G) linear distances that are significantly different in shape by 
confidence interval testing and differ by up to 5% or more between WT and KO mice. Distances that are 
greater in WT than KO mice are drawn in blue, and those that are greater in KO than WT mice are 
drawn in pink. (A) rostral , (B) caudal, (C)  supero-rostral views of the mouse right femur. (D) rostro-
medial, (E) caudal, (F) medial, (G) lateral views of right humerus. 
 
 
 
 
 
 
A 
B 
C 
D 
E 
F 
G 
WT greater than KO by intervals of 5-9% to 6-12% 
KO greater than WT by intervals of 1- 5% to 2-6% 
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4.1.2.3 Shape Variance and Correlations 
 
Based on confidence interval tests calculated in MIBoot, the variance in distances 
between groups did not differ significantly for femoral or humeral data. 
A regression on age for individual distances was performed; those distances that were 
found to be significantly correlated with age (p>0.05) are indicated in Supplementary 
Tables 5-11; these distances were not included in Results (Figures 5,6).  
 
 
4.2 Bone Mineral Density and Weight Comparisons 
 
Table 3. Femoral/Humeral Bone Mineral Density and Length and Full Body Weight 
Measurement Summary Statistics  
 
              WT                             KO 
Welch’s t-test Wilcoxon Rank  
Sum Test 
 N Mean SD N Mean SD t score p value W p value 
Femur BMD  
(mg/cm
3
) 
 
10 14.75 
 
2.81 
 
10 16.77 3.54 
 
1.42 
 
0.17 
 
28 0.11 
Humerus BMD 
(mg/cm
3
) 
 
10 14.76 
 
2.41 
 
10 15.41 2.13 
 
0.64 
 
0.53 41 0.53 
Weight (g) 10 26.3 
 
2.97 
 
10 24.62 1.58 
 
1.57 
 
0.14 
 
60 0.47 
Femur Length 
(mm) 
 
8 15.27 
 
0.48 
 
8 14.36 
 
0.33 
 
4.87 
 
0.00017* 
 
95 0.00021* 
Humerus Length 
(mm) 
 
8 11.56 
 
0.33 
 
8 11.18 
 
0.25 
 
2.85 
 
0.01 * 
 
79 0.034 * 
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Bone mineral density of femora and humeri was slightly greater in KO than WT mice 
(Figure 7, Table 3). However, this difference is statistically insignificant as calculated 
using Welch’s t-test and Wilcoxon rank sum test (Table 3). 
 
Wildtype mice were slightly heavier than KO mice as depicted in Figure 8 (mean weight: 
WT 26.3g, KO 24.6g).  However, this difference in weight is statistically insignificant as 
determined by Welch’s t-test and Wilcoxon rank sum test (Table 3). All mouse weights 
are listed in supplementary Table 12.  
 
Bone length was greater in WT mice than in KO mice and this difference is statistically 
significant as determined by Welch’s t-test and Wilcoxon rank sum test (Table 3). All 
mouse femoral/humeral lengths are listed in supplementary Table 13.  
 
Figure 7. (A) The average bone mineral densities of WT and KO femora were compared. 
KO femora demonstrated a slightly higher bone mineral density than WT, although the 
difference was not statistically significant. (B) The average bone mineral densities of WT 
and KO humeri were compared. KO humeri demonstrated a slightly higher bone mineral 
density than WT, although the difference was not statistically significant. Boxes represent 
the 25th-75th percentile range, with the horizontal dark line indicating the median; 
whiskers extending to the maximum and minimum values within 1.5 box lengths. Outliers 
are indicated by   . 
A B 
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Figure 8. The average weight of the WT and KO groups at the time of scanning were 
compared. Differences in weight were not statistically significant (Table 3). Boxes represent 
the 25th-75th percentile range, with the horizontal dark line indicating the median; 
whiskers extending to the maximum and minimum values within 1.5 box lengths.  
 
 
Figure 9. (A) Femur, and (B) Humerus bone lengths were compared between KO and WT 
mice. WT mice demonstrated significantly longer bone lengths than KO mice (Table 3). 
Boxes represent the 25th-75th percentile range, with the horizontal dark line indicating the 
median; whiskers extending to the maximum and minimum values within 1.5 box lengths. 
 
  
A B 
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4.3 Cross-Sectional Geometry Analysis 
 
Cross-sectional properties of femora and humeri were compared between WT and KO 
mice.  
 
After correction for multiple tests using the Bonferroni correction, significant differences 
were found for the polar second moment of area, J, in both bones and for CA in the femur 
as determined by Welch’s t-test and Wilcoxon rank sum test (Table 4, Figures 10, 11 (A, 
C)). For all three differences, KO mice had greater measures than WT. Using this 
conservative measure of significance, CA was not significantly different in the humerus 
although the trend of greater CA in KO than in WT mice remains.   Thus, KO mouse long 
bones demonstrate greater resistance to torsion (J) and compression (CA). Although KO 
mice have greater cortical area (CA), the proportion of cortical area to the whole section, 
as described by percent cortical area (%CA) was not significantly different between the 
groups (Table 4, Figures 10, 11 (B)).  Additionally, the shape of the cortical cross-section 
that describes the distribution of cortical bone (Imax/Imin) was not significantly different 
between the groups (Table 4, Figures 10, 11 (D)).  These results indicate that KO femora 
and humeri are thicker than WT, but that the proportion and distribution of cortical bone 
are similar between groups. 
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Table 4. Standardized Cross-Sectional Properties, WT vs KO 
All t-tests assumed unequal variances between groups.  Therefore, a Welch’s t-test was 
used. As sample sizes were small, a Wilcoxon rank sum test was also used. (Results coincide 
between tests).  All data were normally distributed. 
J, polar second moment of area; CA, cortical area; %CA, percent cortical area; Imax, 
maximum second moment of area; Imin, minimum second moment of area; Imax/Imin, 
diaphyseal shape. 
 
 
 
 
 
 
 
 
 
 
 
 
  
Cross-
Sectional 
Property 
Summary Statistics  
 
            WT                             KO 
Welch’s t-test Wilcoxon 
Rank  
Sum Test 
 N Mean SD N Mean SD t score p value W p value 
Femur J 8 0.13 
 
0.016 
 
8 0.19 0.026 
 
5.72 
 
0.00010 * 
 
0 0.00016 * 
Femur CA 8 56.91 
 
3.71 
 
8 70.53 5.88 
 
5.54 
 
0.00012 * 0 0.00016 * 
Femur %CA 8 66.76 
 
1.8 
 
8 69.17 4.33 
 
1.45 
 
0.18 
 
19 0.19 
Femur Imax/Imin 
 
8 1.97 
 
0.13 
 
8 2.00 
 
0.20 
 
0.26 
 
0.80 
 
29 0.80 
Humerus J 8 0.049 
 
0.005 
 
8 0.060 
 
0.007 
 
3.78 
 
0.002 * 
 
7 0.007 * 
Humerus CA 8 33.01 
 
2.68 
 
8 36.43 
 
2.57 
 
2.60 
 
0.021  
 
12 0.04  
Humerus %CA 8 83.15 
 
1.49 
 
8 83.16 
 
2.15 
 
0.014 
 
0.99 
 
26 0.57 
Humerus 
Imax/Imin 
 
8 1.41 
 
0.1 
 
8 1.36 
 
0.09 0.97 
 
0.35 
 
42 0.33 
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Femur: Cross-Sectional Geometry 
 
 
  
 
Figure 10. (A) Femur cortical area, (B) Femur percent cortical area (cortical area/total 
subperiosteal area X 100), (C) Femur midshaft torsional rigidity (J), and (D) Femur 
midshaft shape (Imax/Imin).  All values have been standardized by body size. Boxes represent 
the 25
th
-75
th
 percentile range, with the horizontal dark line indicating the median; whiskers 
extending to the maximum and minimum values within 1.5 box lengths. Outliers are 
indicated by   . 
  
C. D
. 
A. B. 
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Humerus: Cross-Sectional Geometry 
 
 
Figure 11. (A) Humerus cortical area, (B) Humerus percent cortical area (cortical area/total 
subperiosteal area X 100), (C) Humerus midshaft torsional rigidity (J), and (D) Humerus 
midshaft shape (Imax/Imin).  All values have been standardized by body size. Boxes represent 
the 25
th
-75
th
 percentile range, with the horizontal dark line indicating the median; whiskers 
extending to the maximum and minimum values within 1.5 box lengths. Outliers are 
indicated by   . 
 
A
. 
B
. 
C
. 
D
. 
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5 Discussion 
 
The pannexin family of channel forming glycoproteins has received increasing attention 
as their diverse roles in physiology and disease continue to be uncovered. Of the three 
members of this family, Panx3 has been the least studied, in part, owing to its limited 
expression profile. Current research finds Panx3 is highly expressed in skeletal tissues; in 
growing long bones, it is induced at the growth plate where it has a role in regulation of 
proliferation and differentiation of cartilage and bone-forming cells.  
 
This study analyzed the phenotypic aspects of humeri and femora in a novel knockout 
mouse that is devoid of Panx3 in all tissues. Results find distinct shape differences 
between the long bones of the Panx3 KO mouse compared to wildtype controls. PCA 
analysis indicates that a significant portion of this shape difference (20-30% for the 
femora and humeri respectively) is attributed to the allometric component of shape.  
 
Analysis of landmark coordinate data using EDMA then brought to light the nature and 
magnitude of some of these proportional differences between KO and WT long bones. In 
the EDMA “form” analysis, which includes all size components of the landmark 
configurations, approximately half of the interlandmark distances were significantly 
different between the two groups for both humeral and femoral form analyses. Of these 
significantly different distances, all (but one) were larger in WT mice than in the KO 
mice.  All of these distances that were larger in WT involved measures of diaphyseal 
length. From this analysis, it is concluded that the long bones of the WT mice have longer 
diaphyses than those of KO mice when scale is included.  Length measures obtained from 
CT data confirmed a significant overall bone length difference between the two groups. 
In EDMA “shape” analysis, a scaling factor is used to “size-correct” configurations to 
elucidate differences that can be overwhelmed when scale is included. Once scaled in this 
manner, over half of the distances were significantly different between groups for both 
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long bones analyzed. Of those significantly different distances, a notable number (25% in 
femur and 47% in humerus) were larger in KO than in WT. The majority of distances that 
were larger in KO in the shape analysis span from the proximal metaphysis to a bony 
prominence for large muscle attachment (third trochanter in femur, deltoid tuberosity in 
humerus). With the exception of two distances in the humerus, the remainder of the 
distances that were significantly greater in KO than WT were within the third 
trochanter/deltoid tuberosity or within the ephiphyses. In shape analysis as with form 
analysis, all of the distances that were greater in WT than in KO mice were measures of 
diaphyseal length. From shape analysis it is concluded that WT mice have proportionally 
greater measures of diaphysis length than KO mice, and KO mice have proportionally 
larger regions of muscle attachment and epiphyses than WT mice.  
 
The compromised length of long bones noted in KO mice may be explained on the basis 
of inhibited growth plate expansion in the absence of Panx3. Expression of Panx3 at the 
growth plate promotes the differentiation of chondrocytes to a mature form that begins 
the process of mineralization of the matrix, which is necessary for subsequent bone 
deposition. Panx3 also mediates osteoblast differentiation. Interruption of this process of 
cartilage growth and replacement by bone as may occur in the absence of Panx3 would 
explain compromised longitudinal growth of the bone.    
 
The variance in distances did not differ significantly between groups for either long bone.  
These results suggest that while the loss of Panx3 exerts a phenotypic effect on long 
bones, the effect is consistent.  These results are in stark contrast to studies of mutant 
phenotypes. 
 
The consistent variability in distances within each group suggests that the mechanisms at 
play effect altered proportions of the long bones reliably and any compensatory 
mechanisms influencing growth are not haphazard.  
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Body weight and BMD between WT and KO mice were compared to rule out the 
possibility that long bones in WT mice were larger due simply to a more robust body size 
or that they were different in quality due to their density and mineralization. No 
statistically significant difference was evident for body weight or BMD between the 
groups at the time of scanning. Therefore, the differences in bone shape do not appear to 
be related to overall body mass. As well, although Panx3 appears to affect the bone 
shape, mineralization does not appear to be affected. Panx3 promotes the differentiation 
of chondrocytes and osteoblasts that is required for bone mineralization, however, even in 
the absence of Panx3, mechanisms must be in place that allow for the collection of 
factors such as alkaline phosphatase, that are necessary for adequate mineralization.   
 
Results of cross-sectional geometric property analyses indicate differences in bone 
distribution between groups.  The cross-sectional geometry of long bones can predict 
mechanical properties of bones such as strength and rigidity (Ruff and Hayes 1983). The 
second polar moment of area (J) and cortical bone area (CA) were significantly greater in 
KO mice than in WT mice.  These results indicate that the long bones of KO mice have 
greater torsional (J) and compressive (CA) resistance than WT mice.  Cross-sectional 
shape (Imax/Imin) and the percentage of cortical bone area to total cross-sectional area 
(%CA) were not significantly different between groups indicating a consistently thicker 
diaphyseal cross-section in the long bones of the KO mice. As body weight and bone 
mineral density did not differ significantly between groups, the more robust diaphysis of 
KO mice cannot be explained on those grounds. As well, both groups of mice were 
similarly housed and there were no overt differences in their patterns or levels of activity.  
 
A previous experiment by Ishikawa et al (2011) found that ex vivo growth of a murine 
newborn metatarsus in the presence of a Panx3 channel inhibitor resulted in compromised 
growth in both length and width.  While the results of our current study were congruent 
with compromised longitudinal growth, in contrast to this ex vivo preparation, we found 
that in vivo, Panx3 null individuals demonstrated thicker diaphyses. As well, it is of note 
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that gross measurement of long bones in Panx3 KO mice up to 6 weeks of age did not 
demonstrate any anomalies in previous studies by Moon et. al (2015).  Taken together, 
these results may suggest that in the absence of Panx3, long bone size is not 
compromised during development, but optimal growth may require Panx3. Alternatively, 
the difference in murine long bone size in vivo may be too subtle to detect by gross 
measurement and require increased measurement precision as provided by micro-CT 
imaging.  
 
Results of our study suggest that Panx3 affects bone differently depending on the location 
and/or type of bone involved. We found decreased bone length, suggesting compromised 
longitudinal growth which implicates inhibition of the process of endochondral 
ossification at the growth plate. However, KO mice were proportionally larger than WT 
mice in areas that are mainly comprised of trabecular bone such as metaphyses/epiphyses 
and large muscle attachment sites. Additionally, KO mice had greater cross-sectional 
cortical area of diaphyses than WT mice.  
 
In long bones, deposition of bone can occur on various surfaces. In periosteal 
ossification, osteogenic cells deposit bone on the periosteum (outer layer); in endosteal 
ossification bone is deposited by cells on the endosteum (inner bone layer); in 
perichondral ossification bone is deposited on mineralized cartilage by osteogenic cells 
brought into the marrow cavity; and in endochondral ossification, mineralized cartilage is 
resorbed and bone is deposited on cartilaginous spicules (Hall, 2005).  Deposition of 
cortical bone in the diaphysis is accomplished by periosteal ossification where growth is 
appositional (deposited on top of an existing surface).  However, in the metaphysis, it 
appears that cortical bone is created from the endosteal surface when trabeculae (formed 
by endochondral ossification) in the periphery of the growth plate enlarge and “coalesce” 
(Cadet et al. 2003).  This process appears to increase both cortical girth and length in the 
metaphysis. Bone resorption then occurs at the periosteal surface to reduce the 
metaphyseal surface to the width of the diaphysis. Trabeculae formed nearer to the centre 
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of the growth plate are greatly resorbed to form the marrow cavity. There is increased 
osteoblast density at the peripheral trabeculae that appear to be responsible for the 
enlargement and coalescence of trabeculae at the periphery; the increased osteoblast 
density may be induced by, as yet unknown factors, from the periosteum (Cadet et al. 
2003). 
 
Trabecular bone is present in the epiphyses and metaphyses, as well as muscle attachment 
sites (ie. trochanters and tuberosities) of long bones. Cortical bone forms the outer shell 
of long bones and largely makes up the diaphysis. Proportional differences seen in this 
study may be related to the processes that regulate the differential deposition and/or 
resorption of trabecular and cortical bone in different regions of the bone.  
 
Panx3 is known to regulate proliferation of osteoprogenitor cells and chondrocytes and to 
regulate differentiation of osteoblasts and chondrocytes. Perhaps its effect on these cells 
depends on the ossification process: ie. cortical vs trabecular, endosteal vs periosteal. It is 
also not yet known if Panx3 affects osteoclasts and hence if Panx3 has an effect on bone 
resorption and remodeling through regulation of these cells.  
 
Another consideration is that the proportionally larger muscle attachment prominences of 
KO mice may be the result of increased strain on these areas due to differential muscle 
loading.  Two species of Panx3 have been identified in skeletal muscle; the species are 
differentially expressed in undifferentiated skeletal muscle cells and myoblasts where 
they have a role in regulation of myoblast proliferation and differentiation (Langlois et al. 
2014). As the Panx3 KO mouse line used in this study lacks the protein in all tissues, 
these mice may demonstrate differences in muscle properties related to its ablation that 
result in changes in the direction, intensity or frequency of muscle action. A difference in 
muscle mass, muscle attachments or density of muscle fibres may contribute to the long 
bone phenotype observed in this study. Alternatively, the bone in the KO mice may be 
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more sensitive to mechanical strain, causing an “over-reaction” of bone deposition in 
response to otherwise typical muscle loading.  
 
5.1 Future Directions 
 
Long bone shape is greatly influenced through muscle-bone interactions.  The 
proportionately larger deltoid tuberosities and third trochanters in the KO mice in this 
study suggest that differences in muscle-bone interactions between the two groups could 
be responsible for the phenotypic differences observed. Thus, a comparison of muscle 
phenotypes between KO and WT mice may add to our understanding of the role of Panx3 
in long bone growth and development. KO mice may have overall increased lean mass, 
increased bulk in a subset of muscles, or differences in muscle quality.  Due to the effects 
of muscle-bone interactions, changes in muscle quantity and/or quality could be 
responsible for the bony changes observed in this study.   
 
Determining if the expression of Panx3 differs by bone surface and/or type (cortical vs 
trabecular) may help determine whether its role varies depending on the region of the 
bone or type of bone.  As well, determining whether or not Panx3 is expressed by 
osteoclasts or whether or not it is also associated with pathways involved in processes of 
resorption will help determine whether Panx3 influences long bone phenotype through 
regulating resorption as well as deposition.  
 
Pannexin biology is a yet young and evolving area of research that holds promise for 
furthering understanding in processes of development, growth, and degeneration with 
implications for unraveling complexities associated with disease and evolutionary 
change. Aspects of long bones that are more prone to altered phenotype may be more 
vulnerable to change under genetic or environmental stress. Therefore, factors such as 
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Panx3 that influence skeletal phenotype may prove useful in applications for prevention 
and treatment of developmental or degenerative bone and joint dysfunction.  Elucidation 
of Panx3’s role in bone biology may also further research into buffering mechanisms that 
ensure a functional phenotype in spite of genetic anomaly, and determine aspects of 
phenotype most given to disruption and therefore most prone to evolutionary change. In 
the study of physiology, developmental and degenerative disease and in probing the 
mechanisms of evolutionary change, the pannexins are implicated as prime targets of 
focus in future research endeavours.   
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Supplementary Tables 
Table 5. Femur Form Data 
Distances that are Significantly Larger in WT than KO 
  
 
   
Table 6. Femur Form Data 
Distances that are Significantly Larger in KO    
than WT 
 
 
 
 
  
Landmark  Landmark Percentage  
Difference 
in gtp 2-6 ◊ 
in pitf 1 ◊ 
in ptt 2-6 
gtp mep 2-7 ◊ 
pitf mep 1-8 
in tgta 2-7 
ptt mep 2-8 ◊ 
in gtl 3-7 
in gts 3-7 
ptt mps 3-8 
pitf mps 2-9 
tgta mep 3-8 
gtp mps 3-8 
ptt lep 3-8 
ptt lps 3-8 
tgta lep 4-8 
tgta mps 3-8 
gtl mep 3-8 
gts lep 4-8 
gts mep 3-8 
gts mps 4-8 
gtl lep 4-8 
pitf lep 3-9 
gtl mps 4-8 
pitf lps 3-9 ◊ 
tgta lps 4-8 
in ditc 4-8 
gts lps 4-8 
in dtt 3-9 
dtt mep 3-10 
gtl lps 4-8 
in ltsd 4-9 
gtp lep 4-9 
gtp lps 4-9 
ditc mps 5-10* 
ditc mep 4-10 
ltsd mep 4-10 
ltsd mps 5-10* 
ditc lep 5-10* 
ditc lps 5-10* 
dtt mps 4-11 
ltsd lps 6-10* 
ltsd lep 6-11* 
dtt lps 6-13* 
dtt lep 7-13* 
Landmark Landmark Percentage  
Difference 
in lep 1-8* 
* Distances that are diagrammed in Figure 5. 
◊ Distances that are significantly correlated 
with age. 
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Table 7.  Humerus Form Data  
Distances that are Significantly 
Larger in WT than in KO 
 
Landmark  Landmark Percentage 
Difference  
 
sc mep 1- 6 
ins lep 2- 6 
pgp lep 3-6 
lgtgp hlt 1 - 9 
mltgp lep 3 - 7 
tdt lep 3 - 8 ◊ 
pdt lep 3- 8 ◊ 
lgtgp lep 4 - 7 
hlt lep 4 - 8 
ins sc 5 – 9* 
pgp sc 5.5 - 9.6* 
mltgp sc 6 – 10* 
ins cf 7 – 11* 
lgtgp sc 7 – 11* 
pdt sc 6 – 12 ◊ 
ddt lep 7 – 11* 
pgp cf 7 – 12* 
hlt sc 7 – 12* 
mltgp cf 8 – 13* 
lgtgp cf 8 – 13* 
hlt cf 8 – 13* 
tdt sc 7 – 15* 
pdt cf 9 – 14 ◊ 
ins mep 10 – 14* 
pgp mep 10 – 14* 
hlt mep 10 – 15* 
lgtgp mep 11 – 15* 
mltgp mep 11 – 16* 
tdt cf 11 – 19* 
pdt mep 12 – 18* 
ddt sc 14 – 20* 
tdt mep 15 – 23* 
ddt cf 16 – 23* 
ddt mep 19 – 26* 
 
 
 
 
  
* Distances that are diagrammed in Figure 6. 
◊ Distances that are significantly correlated 
with age 
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Table 8. Femur Shape Data 
Distances that are Significantly 
Larger in WT than in KO 
 
Landmark  Landmark Percentage  
Difference 
 
 gtp mps 1 - 7 
ptt mps 1-6 
in tgta 1-6 
in gtl 2-7 
dtt mep 1-9 
in gts 2-7 
in dtt 2-8 
ptt lps 2-7 
ptt lep 2-8 
pitf lep 1-9 ◊ 
pitf lps 1-9 
gtp lep 2-8 
gtp lps 2-8 
tgta mep 2-9 
tgta mps 3-9 
dtt mps 3-9 
tgta lep 4-8 
gtl mep 2-10 
gtl mps 4-9 
gtl lep 4-9 
in ltsd 4-9 
gts lep 4-9 
gts mep 3-10 
gts mps 4-9 
tgta lps 4-9 
in ditc 4-9 
gtl lps 5-9 
ltsd mps 4-10 
gts lps 5-10* 
ltsd mep 4-11 
dtt lps 5-11* 
ditc mps 5-11* 
ditc mep 5-12* 
dtt lep 6-12* 
ltsd lps 6-11* 
ditc lep 6-12* 
ditc lps 6-12* 
ltsd lep 6-12* 
* Distances that are diagrammed in Figure 6. 
◊ Distances that are significantly correlated 
with age. 
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Table 9. Femur Shape Data 
Distances that are Significantly Larger in KO than WT 
 
 
 
 
 
 
 
 
  
Landmark  Landmark Percentage  
Difference 
 
gts dtt 2-6* 
ptt dtt 2-7* 
gtl dtt 2-6 ◊ 
dtt tgta 2-5* 
pitf dtt 1-6 ◊ 
gtp dtt 0.5 – 5* 
gts gtp 0.5 – 5* 
in lep 0.4 - 4 
gts ltsd 1- 4 
gts ditc 1 - 4 
gtp ptt 0.1 – 5* 
ditc dtt 0.2 – 4 ◊ 
in mep 0.1 - 3 
* Distances that are diagrammed in Figure 6. 
◊ Distances that are significantly correlated 
with age. 
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Table 10. Humerus Shape Data.  
Distances that are Significantly Larger in WT than KO 
 
 
 
 
 
 
 
 
 
 
 
  
Landmark  Landmark Percentage  
Difference 
 
 ins sc 1 - 5 
pgp sc 2 - 6 
ddt lep 3 - 6 
mltgp sc 3 - 7 
tdt sc 3 - 8 
pdt sc 4 – 9 ◊ 
lgtgp sc 5 – 9* 
hlt sc 5 – 10* 
ins cf 6 – 8* 
pgp cf 7 – 9* 
mltgp cf 8 – 11* 
ddt sc 7 – 11* 
lgtgp cf 9 – 11* 
tdt cf 9 – 12* 
hlt cf 9 – 12* 
pdt cf 9- 13 ◊ 
ddt cf 12 – 15* 
ins mep 12- 15* 
pgp mep 13 – 17* 
hlt mep 13 – 17* 
lgtgp mep 14 – 18* 
mltgp mep 14 – 18* 
tdt mep 15 – 18* 
ddt mep 17 – 20* 
pdt mep 16 – 21* 
* Distances that are diagrammed in Figure 6. 
◊ Distances that are significantly correlated 
with age. 
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Table 11. Humerus Shape Data  
Distances that are Significantly Larger in KO than WT 
 
 
 
 
 
 
 
 
 
 
  
Landmark  Landmark Percentage 
Difference 
 
ins ddt 7.5 – 9* 
ins tdt 5.5 – 8* 
mltgp ddt 5 - 7.5* 
pgp ddt 5.2 – 7 ◊ 
hlt ddt 3.3 – 7* 
pgp tdt 3.5 – 6*  
mltgp tdt 3 – 6* 
lep sc 3 - 5.6* 
hlt tdt 2 – 6* 
pdt ddt 2 – 5 ◊ 
lgtgp ddt 2 – 5* 
ins pdt 2 – 5* 
pgp pdt 1 - 4.5 
ins lep 1 - 4.5 
ins hlt 1 - 4 
lgtgp tdt 1 - 4 
lep cf 1 - 4 
ins lgtgp 1 - 4 
pdt tdt 1 – 4 ◊ 
pgp lep 0.5 - 4 
lep mep .3 - 4 
pgp lgtgp .5 - 4  
* Distances that are diagrammed in Figure 6. 
◊ Distances that are significantly correlated 
with age. 
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Table 12. Weight of Mice at Time of Scanning 
 
KO 
Individual 
Weight at Time of Scanning 
(g) 
WT 
Individual  
Weight at Time of Scanning 
(g) 
KO1 21.5 WT1 24.3 
KO2 23.1 WT2 24.7 
KO3 25 WT3 24.6 
KO4 25.4 WT4 23 
KO5 25.5 WT5 28.5 
KO6 27.1 WT6 25.6 
KO7 24.8 WT7 24.6 
KO8 25.9 WT8 31.2 
KO9 24.3 WT9 31.3 
KO10 23.6 WT10 25 
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Table 13. Length of Femora and Humeri at Time of Scanning 
 
KO 
Individual 
Length at Time of 
Scanning (mm) 
WT 
Individual  
Length at Time of 
Scanning (mm) 
 
Femur Humerus Femur Humerus 
KO1 
14.02 10.89 
WT1 
14.83 11.36 
KO2 
13.93 11.07 
WT2 
14.53 11.49 
KO3 
14.26 10.83 
WT3 
14.93 11.26 
KO4 
14.44 11.4 
WT4 
15.02 11.36 
KO5 
14.74 10.96 
WT5 
15.44 11.76 
KO6 
14.96 11.05 
WT6 
15.32 11.2 
KO7 
14.11 11.52 
WT7 
15.42 11.56 
KO8 
14.46 11.15 
WT8 
16 12.19 
KO9 
14.58 11.49 
WT9 
16.03 12.03 
KO10 
14.1 11.39 
WT10 
15.14 11.34 
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Appendices 
Appendix A: Principal Components Analysis (PCA) Supplement 
Reference (Zelditch, Swiderski, and Sheets 2012) 
PCA is a data reduction method of data analysis that is helpful for simplifying the 
description of variation. The original variables are replaced with new variables (principal 
components) that describe the direction of greatest variance. Because the majority of the 
variation in a sample can usually be described with only a few principal components, the 
new variables simplify variation and also depict how the variation is distributed in the 
forms.  PCA can be useful for visualization and interpretation of differences.  
 
Principal components are the directions of greatest variance. Graphically, they are the 
directions where the data is most spread out.  
 
Figure I shows data points for two observed traits, X and Y. Each point is the observation 
for a single specimen. First, the direction that describes the largest amount of the variance 
is found by finding the direction through the scatter where the data has the greatest 
spread. In Figure II, the ellipse enclosing the data points depicts the range of the variance. 
The long axis of the ellipse is the line where the data has the greatest spread. To minimize 
the variance that is not described, the line is drawn so as to minimize the sum of squared 
distances from the data points to the line (Figure III). This line is the first principal 
component that describes the maximum amount of variance among the points.  
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Figures modified from (Zelditch, Swiderski, and Sheets 2012) 
 
 
 
PC1
Y
Figure II:  an ellipse enclosing the data 
points illustrates the range of variance of 
traits X and Y 
Figure I : Scatter plot of individuals 
with two observed traits X and Y 
Figure III: The line that can be drawn along the long axis of the ellipse 
that minimizes the squared distances of the data points to that line is 
the first principal component (PC1) representing the maximum portion 
of variance.  
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In a simple case such as this example, because there are only two variables, all of the 
variation that is not described by the first axis (PC1) is described by the second axis of 
the ellipse (PC2). After the variation in the original variables has been described in terms 
of PCs, the next step is to determine the positions of the individuals relative to these new 
axes (Figure IV). The point where the PCs intersect is the sample mean. The PC scores 
represent the distances of the individual from the mean in the directions of the PCs. The 
PCs become the axes of a new coordinate system that allows us to view the data from a 
different perspective. The relative positions of the data points remain the same. These 
axes represent the direction where there is the most variation, and therefore the most 
information.  
 
 
 
Math using eigenvectors and eigenvalues can be used to find the principal component 
rather than graphic representation. An eigenvector is a direction, for example, the slope of 
the line. Every eigenvector has an eigenvalue which is a number representing the extent 
of variance in that direction. The eigenvector with the highest eigenvalue is therefore the 
principal component.  The number of eigenvectors/values that exist equal the number of 
Figuew IV: The purple circle represents an individual data point in the sample. Pcs1 and pcs2 are the 
principal component scores of the individual on PC1 and PC2 that are distances from the mean 
(intersection of PC1 and PC2). Figures modified from (Zelditch, Swiderski, and Sheets 2012) 
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variables or dimensions of the data. In a 2-variable data set, PC1 is the first eigenvector 
and PC2 is the second.  
 
PCA can be used to reduce the dimensions of the data to provide a view of the greatest 
variation while stripping away the unnecessary components. In a 3-variable data set for 
example, the first and second eigenvector would describe the vast majority of the 
variation and the third eigenvector would be very small so that it could be discarded from 
the view, thereby reducing the traits or variables that need be considered.  PCA finds the 
axes of greatest variation in the dataset and reduces the number of variables viewed. This 
type of analysis is appropriate for statistical comparisons with smaller sample sizes where 
there are many variables and few specimens.  In this way, data is simplified and it is 
easier to visualize and interpret the extent and distribution of variance. 
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Appendix B: Euclidean Distance Matrix Analysis (EDMA) 
Supplement 
Reference (Lele and Richtsmeier 2001) 
 
Throughout the discussion of EDMA, form refers to representations that include aspects 
of size and shape of the object. Shape refers to a ‘size-corrected’ form in which a scaling 
factor has been applied to investigate the differences that can be overwhelmed when scale 
is included.  
 
EDMA Basics  
 
Landmark data was further analyzed using EDMA. This approach uses matrix algebra. A 
matrix is a rectangular arrangement of values (referred to as elements) that are organized 
into rows and columns. In the explanations that follow, i represents the rows and j 
represents the columns. The symbol, a, denotes an element in the matrix. Therefore, aij 
denotes the element in the i-th row and the j-th column.  
 
To accomplish this analysis, the landmark coordinates were used to calculate all possible 
linear distances (Euclidean distances) between landmark pairs. A matrix consisting of 
these distances is known as the form matrix (FM) of the object. This matrix represents the 
object being examined and this representation does not change with any translation, 
rotation or reflection of the object; therefore, this approach eliminates the influence of 
these parameters on the results. The form matrix is square (the number of rows equals the 
number of columns) and it is symmetric (aij = aji). 
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The form matrix is a square, symmetric matrix where dij is the Euclidean distance 
between landmarks i and j. For example, the element, d1,2 in the diagramed form matrix 
below for object X, indicates the distance between landmark 1 and landmark 2. Where K 
is the number of landmarks, the number of unique pair-wise linear distances in a form 
matrix is K (K-1)/2 (Lele and Richtsmeier 2001).  
 
 
                 
                 0     d1,2     d1,3     d1,4     …   d1,k  
FM(X) =  
                 d2,1    0       d2,3     d2,4     …   d2,k 
  
                d3,1    d3,2     0      d3,4    …   d3,k 
 
 
Because the matrix is symmetric, it can be abbreviated by collecting all elements above 
the diagonal and expressing them as a vector (a matrix that has only 1 column).  
 
When comparing two objects, X and Y, their form matrices FM(X) and FM(Y) are 
compared and the difference between forms is expressed as a form difference matrix 
(FDM). Elements of the form difference matrix correspond to the ratios (division of an 
element in one form matrix by its corresponding element in the other form matrix) of the 
linear distances. 
 
When comparing groups, the mean form must be estimated for each group. The mean 
form matrix can be thought of as the average of the linear distances from all forms in the 
sample. The mean form difference matrix represents the difference between the mean 
forms of each group.  
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To account for size differences, the geometric mean of all distances can be used as a 
scaling factor to create a shape matrix. The outcome is size-corrected forms that, when 
compared, are considered a comparison of shape. The mean shape difference matrix 
represents the shape difference between sample groups. The elements of the shape 
difference matrix correspond to the difference between like linear distances of the two 
shape matrices.  
  
81 
 
Appendix C: Permissions 
 
Confirmation Number: 11348656 
Order Date: 04/27/2015 
Order Details 
Biochimica et biophysica acta. Biomembranes  
 Order detail ID: 66857472  
 ISSN: 0005-2736  
 Publication Type: Journal 
 Volume:  
 Issue:  
 Start page:  
 Publisher: ELSEVIER BV 
 Permission Status:  Granted 
 Permission type: Republish or display content 
 Type of use: Thesis/Dissertation 
Order License Id: 3617220628131 
82 
 
Curriculum Vitae 
 
Name:   Deidre Caskenette 
 
Post-secondary  University of Guelph 
Education and  Guelph, Ontario, Canada 
Degrees:   1994-1998 B.Sc.  
 
The University of Western Ontario 
London, Ontario, Canada 
2013-2015 M.Sc. 
 
 
Honours and  Western Graduate Scholarship 
Awards:   2013-2015 
 
   Poster Presentation Finalist  
   American Association of Anatomists 
   2015 
 
Nominated for W.H. Boyd Scholarship 
(Highest Grade in Human Anatomy) 
1997 
 
 
Related Work Experience  
Teaching Assistantships 
University of Western Ontario, London, Ontario 
 
Human Gross Anatomy Teaching - Lab                                                Jan 2015 – Apr 2015 
Component for First and Second Year Medical Students  
 
 
Head Teaching Assistant for Systemic Human Anatomy Online        Sept 2014 - Apr 2015 
 (ANATCELL 3319) 
 
 
Systemic Human Anatomy Online                                                         May 2014 - Aug 2014 
 (ANATCELL 3319) 
 
83 
 
Human Functional Anatomy                                                                           Jan 2014 – Apr 2014 
for School of Nursing (HEALTSCI 2330B) 
 
 
Teaching Assistant for Human Gross Functional Anatomy 
for    School of Physiotherapy (ANATCELL 9501) /                Sept 2013 – Mar 2014 
School of Occupational Therapy (ANATCELL 9524)   
  
 
Guest Lectures 
University of Western Ontario, London, Ontario 
 
Guest Lecturer for Histology Pre-Lab Talk for Mammalian Apr 7, 2014  
Histology (ANATCELL 3309) 
 
 
Guest Lecturer for Tutorial for Clinical Mammalian Histology Mar 3, 2014 
(ANATCELL 9561)  
University of Western Ontario, London, Ontario 
 
Functional Anatomy for School of Nursing     Feb 27,2015 
(HEALTSCI 2330B 001) 
University of Western Ontario, London, Ontario 
 
PRESENTATIONS 
•Caskenette, D., Laird, D.W.,  Wilson, T.,  Merrifield,P.,  Penuela,  S., Willmore, K. (2014, 
October) Phenotypic Analysis of Long Bones in Pannexin 3 Knockout Mice Using a 
Geometric Morphometric Approach. Poster Presented at the Western Anatomy and Cell 
Biology Research Day, London, Ontario. 
•Caskenette, D., Laird, D.W.,  Wilson, T.,  Merrifield,P.,  Penuela,  S., Willmore, K. (2014, 
October) Phenotypic Analysis of Long Bones in Pannexin 3 Knockout Mice Using a 
Geometric Morphometric Approach. Poster Presented at Experimental Biology Symposium 
2015, Boston, Massachusetts. 
•Invited Platform Presentation (2015, March) Phenotypic Analysis of Long Bones in Pannexin 
3 Knockout Mice Using a Geometric Morphometric Approach. Talk presented at Nexin 
Forum, London, Ontario. 
 
84 
 
VOLUNTEER EXPERIENCE 
 
Foot Clinic Volunteer Sept 26, 2014 
University of Western Ontario, London, Ontario 
 
 Assisted with dissections of foot and lower limb and acted 
as a resource in a workshop for foot care practitioners. 
 
Let’s Talk Science Graduate Student Volunteer Sept 2013 – Jun 2014 
University of Western Ontario, London, Ontario 
 
 Performed demonstrations illustrating scientific principles 
and interacted with elementary school students 
participating in activities designed to educate and inspire 
children regarding scientific discovery. 
 
